Physician profile
Andrea Beatty
NPI 1790201655
$4,762.37
in general payments reported to CMS, 2019-2025
19 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $680 · 2022: $392 · 2023: $903 · 2024: $1,617 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,689.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,332.10 | 2021-2025 | Tecvayli, Darzalex, Carvykti |
| Glaxosmithkline, LLC. | $593.14 | 2021-2025 | Jemperli, Zejula |
| E.R. Squibb & Sons, L.L.C. | $476.70 | 2021-2025 | Opdivo, Breyanzi, Yervoy |
| Merck Sharp & Dohme LLC | $362.44 | 2021-2025 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals Lp | $334.95 | 2021-2025 | Calquence |
| Immunogen, INC. | $254.79 | 2023-2024 | Elahere, Elahere |
| Secura Bio, INC. | $217.73 | 2024 | Copiktra |
| Regeneron Healthcare Solutions, INC. | $160.68 | 2021-2022 | |
| Medtronic, INC. | $156.78 | 2024 | Abre |
| Pfizer INC. | $151.22 | 2021-2025 | |
| Davol INC. | $142.99 | 2023 | Arista Ah Flexitip |
| Menarini Silicon Biosystems, INC. | $125.24 | 2024 | |
| Lilly USA, LLC | $117.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.47 | 2023 | Fruzaqla |
| Gilead Sciences, INC. | $113.46 | 2023 | Trodelvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $34.95 | 2021 | |
| Exelixis INC. | $30.38 | 2021 | |
| Daiichi Sankyo INC. | $24.85 | 2024 | Enhertu |
| Abbvie INC. | $16.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.